meso trials at memorial sloan kettering lookign for recruits

[RandyW]

The Memorial Sloan-Kettering Cancer Center in New York City is planning on conducting three clinical trials to test various methods of treatment for mesothelioma. The center is currently seeking participants for each of these studies.

Malignant mesothelioma is a form of cancer that most commonly develops in the lining of the lungs. There is no cure for this cancer and most treatment options only offer palliative care. The primary cause of this rare disease is exposure to asbestos and patients often do not exhibit symptoms until it has reached the advanced stages of development.

One of the trials being performed will use the investigational drug CBP 501, which is an enzyme that affects cell division in cancerous cells. In addition to receiving CBP 501, patients will also be given the chemotherapy drugs Alimta and Cisplatin, both of which are commonly used in standard treatments for mesothelioma.

A second trial will evaluate the effectiveness of Everolimus, which affects mTOR, a molecule that helps cancer grow. Anyone trying to qualify for this clinical trial must have adequate lung function.

The third clinical trial will study the use of chemotherapy followed by Intensity Modulated Radiation Therapy. Those entering this trial cannot have any previous history involving chemotherapy or radiation treatment.

All patients interested in participating in these clinical trials will be evaluated by the Sloan-Kettering research team to determine if they qualify.

Additional information about mesothelioma may be found through the Mesothelioma Center.

<< Mesothelioma Research Identifies Another Prognostic Factor That Could Improve Treatment

Mesothelioma Research Finds Promising Results with Proton Therapy >>

This entry was posted on Wednesday, April 14th, 2010 at 4:19 pm and is filed under Mesothelioma, Mesothelioma Research, Mesothelioma Treatment. You can follow any responses to this entry through the RSS feed. Responses are currently closed, but you trackback from your own site.

Comments are closed.

mesothelioma-packet

Name:

Address:

City, State, Zip:

Country:

Phone Number:

Email:

Diagnosis:

Comments:

terms of use

asbestos awareness wristbands

click here

Nutrition & Dieting for Cancer

Learn what foods to eat, which to avoid, and the best supplements for the fight against cancer and chemotherapy recovery. cancer nutrition

click here

Veterans Assistance

Asbestos.com has experienced navy veterans on staff to assist veterans in answering questions about applying for asbestos-related VA Claims and other benefits. asbestos navy ships

click here

*Asbestos.com is not affiliated with the

U.S. Department. of Veterans Affairs.

Naval Ships Index

Search through our extensive list of ships that used asbestos-containing products.

(e.g. USS Alabama BB 60)

Mesothelioma Books

Two must read books for anyone who has or who is caring for someone with mesothelioma. mesothelioma books

click here

Get a Free Copy of Lean on Me or 100 Questions & Answers About Mesothelioma.

Enroll in our Newsletter

Receive a copy of our monthly newsletter

with the latest clinical trials, survivor stories,

doctor profiles, and more.

Feature Story

" Mike Dews, 9-Year Mesothelioma Survivor"

Mesothelioma News

rss news tag

* Mesothelioma Diagnostic Marker Identified by Japanese Researchers

04/20/2010 - Mesothelioma researchers have identified another diagnostic marker and potential treatment target that could suppress mesothelioma cell growth.

read more

* Former Shipyard Workers Still Susceptible to Developing Mesothelioma

04/19/2010 - Approximately 2,000 to 3,000 people are diagnosed with mesothelioma in the United States each year. Navy veterans make up a significant amount of thos..

read more

* Mesothelioma Clinical Trial in Italy Tests the Use of NGR-hTNF

04/16/2010 - In a recent press release issued by MolMed S.p.A., an Italian biotechnology company, a Phase III clinical trial for malignant pleural mesothelioma pat..

read more

This website is certified by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: Verify Here.